首頁 › 前列腺癌 › 猶他州 › Salt Lake City
Salt Lake City, UT 的 前列腺癌 臨床試驗
15 項針對 前列腺癌 的研究正在 Salt Lake City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
招募中2 期
- Huntsman Cancer Institute and Hospital, Salt Lake City
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- LDS Hospital, Salt Lake City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- University of Utah - Huntsman Cancer Institute, Salt Lake City
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- Huntsman Cancer Institute, Salt Lake City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- LDS Hospital, Salt Lake City
- 還有 1 項
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
招募中3 期
- Research Site, Salt Lake City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
招募中1 期
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
招募中2 期
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
招募中3 期
- Huntsman Cancer Institute, Salt Lake City
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
招募中
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- START Center for Cancer Care - Mountain Region, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Salt Lake City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
招募中
- University of Utah Huntsman Cancer Institute, Salt Lake City
其他城市的 前列腺癌 試驗
- New York City, NY102 項研究
- Houston, TX75 項研究
- Los Angeles, CA60 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- San Francisco, CA45 項研究
- Chicago, IL45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN43 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Salt Lake City 的其他研究
- 非小細胞肺癌31 項研究
- 乳癌28 項研究
- 癌症（所有類型）27 項研究
- 大腸直腸癌22 項研究
- 黑色素瘤21 項研究
- 多發性骨髓瘤21 項研究
- 肺癌21 項研究
- 轉移性癌症20 項研究
- 卵巢癌19 項研究
- 心臟衰竭17 項研究
- 急性髓系白血病17 項研究
- 肥胖症16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月7日。各研究自行設定資格標準；由研究團隊決定參與者資格。